Grand Pharma Introduces a Global Innovative Product for the Treatment of Demodex Blepharitis and Meibomian Gland Disease with Demodex Mites
R&D Centers
R&D People
Projects in Progress
Grand Pharma Introduces a Global Innovative Product for the Treatment of Demodex Blepharitis and Meibomian Gland Disease with Demodex Mites
The Global Innovative RDC Drug of Grand Pharma ITM-11 Is Approved to Conduct Phase III Clinical Study in China
Grand Pharma Announced Annual Results for the Year Ended 31 December 2023
PHARMACEUTICAL TECHNOLOGY
NUCLEAR MEDICINE ANTI-TUMOR DIAGNOSIS AND TREATMENT AS WELL AS CEREBRO- CARDIOVASCULAR PRECISION INTERVENTIONAL DIAGNOSIS AND TREATMENT TECHNOLOGY
BIOTECHNOLOGY